Gout has roughly tripled since the late 1970s, with about 8 million Americans now suffering from the disease. Patience White, M.D., professor of Medicine in the School of Medicine and Health Sciences, says that while pitching new drugs for gout, pharmaceutical companies have increased people's awareness of the disease and its symptoms.
Gout, a Form of Arthritis, is no Longer Limited to the Well-to-do
Latest News
Alison Hall, PhD, senior associate dean for research at the GW School of Medicine and Health Sciences (SMHS), recently assumed the added role of interim director of the GW Cancer Center following the departure of Julie Bauman, MD. In this Q+A she discusses future plans for the GW Cancer Center.
Abigail Polter, PhD, associate professor of pharmacology and physiology, recently received a grant from the Aligning Science Across Parkinson’s (ASAP) initiative to study a small, but integral part of the mid-brain, called the ventral tegmental area responsible for executive function that she…
Pedro Gazzinelli Guimarães, PhD, assistant professor of microbiology, immunology, and tropical medicine, was recently named among the “New Voices in Microbiology” by the journal Infection and Immunity.
